Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten

J Clin Lipidol. 2022 Sep-Oct;16(5):757-758. doi: 10.1016/j.jacl.2022.08.003. Epub 2022 Aug 20.

Authors

Alpo Vuorio¹, Frederick Raal², Petri T Kovanen³

Affiliations

¹ Mehiläinen Airport Health Centre, Vantaa, Finland; University of Helsinki, Department of Forensic Medicine, Helsinki, Finland. Electronic address: alpo.vuorio@gmail.com.
² Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
³ Wihuri Research Institute, Helsinki, Finland.

No abstract available

Keywords: Cholesterol lowering drugs; Fibrates; Monkeypox; PCSK9 inhibitors; Statins.

Publication types

Letter

MeSH terms

Anticholesteremic Agents*
Cholesterol
Drug Repositioning
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Mpox (monkeypox)*
Proprotein Convertase 9
Public Health

Substances

Anticholesteremic Agents
Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Proprotein Convertase 9